To view the PDF file, sign up for a MySharenet subscription.

ASPEN PHARMACARE HOLDINGS LIMITED - Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements

Release Date: 06/02/2024 12:10
Code(s): APN     PDF:  
Wrap Text
Notification in terms of Section 122(3) of the Companies Act and Paragraph 3.83(b) of the JSE Listings Requirements

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) ("Aspen Holdings" or "Company")
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries
(collectively "Aspen" or "the Company")

NOTIFICATION IN TERMS OF SECTION 122(3) OF THE COMPANIES ACT AND PARAGRAPH 3.83(B) OF THE JSE
LISTINGS REQUIREMENTS

In accordance with section 122(3)(b) of the Companies Act 71 of 2008 ("the Act") and paragraph 3.83(b) of
the JSE Listings Requirements, holders of ordinary shares in the Company are advised that the Public
Investment Corporation SOC Limited has formally notified the Company that it has increased its beneficial
interest in the securities of the Company, which it holds on behalf of its clients, to 20.169% of the ordinary
share capital of the Company, effective 02 February 2024.

Aspen will file the required notice with the Takeover Regulation Panel as required in terms of section
122(3)(a) of the Act.

The board of directors accepts responsibility for the information contained in this announcement, and to the
best of their knowledge and belief, that information is true, and this announcement does not omit anything
likely to affect the importance of the information included.

Durban
06 February 2024

Sponsor:
Investec Bank Limited

Date: 06-02-2024 12:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story